Effect of colchicine on 90-day outcomes in patients with acute myocarditis: a real-world analysis

• Michele Golino,
• Alexa Coe,
• Anas Aljabi,
• Azita H. Talasaz,
• Benjamin Van Tassell,
• Antonio Abbate,
• Roshanak Markley

Affiliations

Michele Golino

Pauley Heart Center, Virginia Commonwealth University, Richmond, VA, United States; Robert M. Berne Cardiovascular Research Center, Division of Cardiology, University of Virginia, Charlottesville, VA, United States

Alexa Coe

Pauley Heart Center, Virginia Commonwealth University, Richmond, VA, United States

Anas Aljabi

Department of Internal Medicine, Virginia Commonwealth University School of Medicine, Richmond, VA, United States

Azita H. Talasaz

Arnold & Marie Schwartz College of Pharmacy and Health Sciences, Department of Pharmacy Practice, Long Island University, New York, NY, USA; Department of Pharmacy, New York-Presbyterian Hospital, Columbia University Irving Medical Center, New York, NY, USA; Department of Pharmacotherapy & Outcomes Sciences, Virginia Commonwealth University, Richmond, VA, United States

Benjamin Van Tassell

Department of Pharmacotherapy & Outcomes Sciences, Virginia Commonwealth University, Richmond, VA, United States

Antonio Abbate

Robert M. Berne Cardiovascular Research Center, Division of Cardiology, University of Virginia, Charlottesville, VA, United States

Roshanak Markley

Pauley Heart Center, Virginia Commonwealth University, Richmond, VA, United States; Corresponding author at: Department of Internal Medicine, Pauley Heart Center, Division of Cardiology, Virginia Commonwealth University, 1200 E. Broad Street, Richmond, VA 23298, United States.